Table I.
On Statin Preoperatively (n = 25,997) | Not On Statin Preoperatively (n = 11,953) | SD After Weighting | ||
---|---|---|---|---|
| ||||
Characteristic | n (%) unless specified | P Value | % | |
Age (median [IQR]) | 73 [67 – 79] | 72 [66 – 79] | < .001 | −1.1% |
Male sex | 20,935 (81%) | 9,234 (77%) | < .001 | −0.9% |
White race | 23,707 (91%) | 10,742 (90%) | < .001 | −0.2% |
EVAR | 20,298 (78%) | 8,959 (75%) | < .001 | −0.2% |
Aortic Diameter (median [IQR]) | 55 [51 – 61] | 57 [51 – 67] | < .001 | 0.3% |
Urgency: | < .001 | 0.7% | ||
Intact | 22,632 (87%) | 8,797 (74%) | ||
Symptomatic | 2,037 (8%) | 1,356 (11%) | ||
Ruptured | 1,295 (5%) | 1,779 (15%) | <.001 | 1.7% |
Center Volume Quartile | ||||
1 st (lowest) | 6,587 (25%) | 3,030 (25%) | ||
2nd | 6,290 (24%) | 3,168 (27%) | ||
3rd | 6,798 (26%) | 3,020 (25%) | ||
4th (highest) | 6,272 (24%) | 2,715 (23%) | ||
Hypertension | 22,644 (87%) | 8,770 (73%) | < .001 | −0.6% |
Diabetes | 5,767 (22%) | 1,557 (13%) | < .001 | −2.7% |
Coronary Artery Disease | 8,933 (34%) | 1,936 (16%) | < .001 | −0.6% |
Congestive Heart Failure | 3,196 (12%) | 965 (8%) | < .001 | −1.7% |
COPD | 8,541 (33%) | 3,858 (32%) | 0.14 | −1.2% |
Chronic Kidney Disease | 9,327 (36%) | 4,047 (34%) | < .001 | −1.1% |
Dialysis | 29 (0.1%) | 22 (0.2%) | 0.053 | −1.1% |
Vascular Disease | 3,588 (14%) | 946 (8%) | < .001 | −3.1% |
Smoking | 22,701 (87%) | 10,166 (85%) | < .001 | −0.2% |
BMI | < .001 | −0.4% | ||
Underweight | 555 (2%) | 463 (4%) | ||
Normal | 6,809 (26%) | 3,808 (32%) | ||
Overweight | 10,148 (39%) | 4,272 (36%) | ||
Obese | 3,410 (29%) | 8,485 (33%) | ||
Medicaid/Self-pay | 617 (3%) | 464 (5%) | < .001 | 0.4% |
Aspirin | 18,892 (73%) | 5,105 (43%) | < .001 | −0.8% |
Any Antiplatelet Agent | 19,662 (76%) | 5,316 (44%) | < .001 | −0.8% |
Beta-Blocker | 16,557 (64%) | 4,905 (41%) | < .001 | .0.5% |
ACE/ARB | 10,475 (50%) | 2,836 (30%) | < .001 | −1.3% |